This leader has taken early-stage MedTech companies from pre-revenue to first international revenues, securing over £20M in funding across R&D, regulatory approval, clinical trials, and commercialisation. Their track record spans hardware and software medical technologies — including Class 2a and 2b devices — with particular depth in CNS, women’s health, and digital health.

They have built the commercial foundations that early-stage companies need most: global partnerships across pharma, insurers, CROs, and healthcare systems; market access and reimbursement strategies across North America, EMEA, and APAC; and the pre-revenue fundraising credibility in regulated fields.

Holding a PhD from a leading global university, with a peer-reviewed publication record in biomedical science, they have served as CEO, Board and Commercial roles at multiple venture-backed and top university spinouts — translating bench-to-bedside science into global launches of clinically-validated products.

They are available for CEO, CCO, or fractional engagements. UK-based with an international mandate.

Download Candidate Profile